BTG buys cryoablution company Galil for $84.5 mln

BTG plc agreed to buy Galil Medical for an initial cash consideration of $84.5 million, and up to $25.5 million in future payments through the end of 2018. Galil provides cryoablution therapies for oncological treatment. Advisors to Galil included Houlihan Lokey, Fredrikson & Byron, Raved Magriso Benkel & Co, Willkie Farr, Gallagher LLP and EY. The Wilkie deal team was led by partners Gordon Caplan and Sean Ewen.

DealsNorth AmericaUSBriefs